Galapagos NV Operating Cycle 2011-2026 | GLPG

Annual Operating Cycle Galapagos NV

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	-	-	-	-	149	73.5	87	90.6	-

All numbers in EUR currency

Maximum	Minimum	Average
149	73.5	100

Issuer	Operating Cycle	Price	% 24h	Market Cap	Country
AgeX Therapeutics AGE	186	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	271	-	-	$ 866 M	China
Midatech Pharma plc MTP	245	-	-18.52 %	$ 27.3 M	Britain
Alexion Pharmaceuticals, Inc. ALXN	12.8	-	-	$ 40.3 B	USA
EyeGate Pharmaceuticals, Inc. EYEG	32	-	-1.52 %	$ 24.7 M	USA
Институт стволовых клеток человека ISKJ	104	-	-	-	Russia
INmune Bio INMB	19.9 K	$ 1.5	-2.55 %	$ 37.1 M	USA
ACADIA Pharmaceuticals ACAD	332	$ 22.89	2.42 %	$ 3.79 B	USA
Advaxis ADXS	88.1	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	115	-	5.93 %	$ 314 M	Canada
AIkido Pharma AIKI	17.9	-	1.93 %	$ 17.4 M	USA
Aptinyx APTX	46.9	-	-39.0 %	$ 4.57 M	USA
Albireo Pharma ALBO	40.8	-	-0.23 %	$ 916 M	USA
Arcutis Biotherapeutics ARQT	291	$ 23.58	0.68 %	$ 3 B	USA
Alpine Immune Sciences ALPN	154	-	-	$ 2.17 B	USA
Aridis Pharmaceuticals ARDS	59	-	17.91 %	$ 11.1 M	USA
CRISPR Therapeutics AG CRSP	1.1 K	$ 53.54	2.21 %	$ 4.81 B	Schweiz
Autolus Therapeutics plc AUTL	129	$ 1.7	3.66 %	$ 452 M	Britain
Ayala Pharmaceuticals AYLA	61.7	-	-	$ 7.46 M	Israel
Завод ДИОД DIOD	64.6	-	-	-	Russia
Фармсинтез LIFE	9.78	-	-	-	Russia
AstraZeneca PLC AZN	206	-	-	$ 96.9 B	Britain
BioDelivery Sciences International BDSI	436	-	-4.8 %	$ 255 M	USA